0
0

What are we, exactly?

BS Weekly #13

That’s the question I keep circling after Mount Vernon. Are we a specialty crop, or are we bait for big ag? Because those are two very different futures, and American elderberry is standing right at the fork.

This June the national elderberry community gathered in Mount Vernon, Missouri. The Heartland American Elderberry Collaborative brought our poster. LIONBERRY REGENERATIVE™ stood alongside Elder Farms and River Hills Harvest. Dr. Andrew Thomas hosted, Buehler Organics and Elder Farms put on a dinner, and researchers, growers, and processors all ended up at the same tables. Good food, good people, real momentum.

But here’s the edge I can’t put down. The moment a crop gets valuable, the commodity machine notices. It comes in offering scale and efficiency, and it leaves behind growers who no longer own anything, working someone else’s market for someone else’s margin. We’ve watched it happen to crop after crop. The question isn’t whether American elderberry is worth that much attention. It’s whether we’ll be the ones holding it when it is.

So why does this crop matter enough to fight over? The science is finally catching up to what growers always sensed. American elderberry is anti-inflammatory in a way that speaks straight to how most of us actually live now, carrying oxidative stress from overprocessed food. And it’s stepping into the GLP-1 and metabolic-recovery moment, where early results on blood sugar and fat oxidation are turning heads. Our native berry isn’t the understudy to European Sambucus nigra either. The American acylated anthocyanin is more protected, more likely to survive processing and reach where it’s meant to work. We are not the lesser version. We are the better one, and we’re only now saying it out loud.

That’s exactly why the fork matters. A crop this promising will get built into a market by somebody. The only question is whose hands stay on it.

Here’s where I land, and where Mount Vernon left me hopeful. We are small, and small is not the weakness everyone assumes. Small means we can actually know each other. It means a grower, a researcher, and a brand can sit at one dinner table and leave understanding each other’s language. That’s how an AgriCluster works. We stick together, we grow the grower base on our own terms, and we build the shared story before anyone builds it for us. We’re standing on fertile ground here, in the dark, underground, where the real trading happens before anything shows on the surface.

More growers, yes. But growers who own it. That’s the whole game.

Facebook
X
LinkedIn

Past Business Weekly's:

METABOLIC RECOVERY – The Next Phase of the GLP-1 Conversation: Metabolic Recovery

Lionberry 's Weekly Delusion and Re-illusion Update.

For the last two years, we’ve been talking about GLP-1 drugs.

Ozempic. Wegovy. Zepbound.

They work.

They reduce appetite, improve blood sugar regulation, and are reshaping metabolic health at scale. This is one of the most significant shifts we’ve seen in decades (Wilding et al., 2021).

But a quieter question is starting to emerge:

What happens after?

Because many people eventually discontinue these medications. They’re expensive, often require ongoing use, and studies have shown substantial weight regain can occur after discontinuation of GLP-1 therapies (Wilding et al., 2022).

Not because people failed.

Because the system that was being supported… is no longer being supported.

I believe we’re entering a new phase of this conversation.

Not just weight loss.

Not just appetite suppression.

But metabolic recovery.

What does the body need to help maintain stability after intervention?

The Washington State University elderberry study led by Professor Patrick Solverson and colleagues, published in 2024, caught my attention immediately (Solverson et al., 2024). Last summer, I also had the opportunity to hear the research presented during the International Elderberry Symposium.

As both an elderberry farmer and a value-added product maker, I was excited to see rigorous science emerging around American elderberry — but also genuinely curious why it wasn’t making larger headlines.

Because the findings were interesting.

In the randomized controlled trial, participants consuming 100% American elderberry juice for one week demonstrated:

  • Reduced blood glucose
  • Lower insulin levels
  • Increased fat oxidation
  • Measurable shifts in gut microbiome activity (Solverson et al., 2024)

Not a miracle.

Not hype.

But a signal.

Because the mechanism matters.

One detail that makes American elderberry especially interesting is that its anthocyanin profile appears to differ from many other dark berries.

American elderberry (Sambucus canadensis) contains significant amounts of acylated anthocyanins — particularly acylated cyanidin-based compounds connected to hydroxycinnamic acid groups (Lee & Finn, 2007; Özgen et al., 2010). These acyl groups alter the chemistry and stability of the anthocyanin molecule.

Why does that matter?

Research suggests acylated anthocyanins demonstrate greater resistance to heat, oxidation, light degradation, and digestive breakdown compared to many non-acylated anthocyanins commonly found in fruits such as blackberries and in many European elderberry varieties (Sadilova et al., 2006; Fuleki & Francis, 1968).

That stability may matter biologically because it potentially allows more intact anthocyanin compounds to survive processing, storage, digestion, and interaction with the gut microbiome.

European elderberry (Sambucus nigra) contains a different anthocyanin composition, dominated more heavily by non-acylated cyanidin 3-glucoside and cyanidin 3-sambubioside compounds (Lee & Finn, 2007). Other berries absolutely contain beneficial anthocyanins too — but American elderberry appears to possess a somewhat distinct anthocyanin architecture that researchers are still working to fully understand.

Researchers believe these anthocyanins interact with the gut microbiome, helping generate short-chain fatty acids and downstream metabolites associated with insulin sensitivity, inflammation regulation, and endogenous GLP-1 signaling pathways (Chambers et al., 2018; Solverson et al., 2024).

Not synthetically.

Endogenously.

Through food and the gut microbiome.

To me, this is where the conversation may be heading next.

Not:

“What replaces GLP-1 drugs?”

But:

“What helps support the body alongside them — and after them?”

Or even:

“What supports metabolic health for people who never start them at all?”

For too long, metabolism has been framed as something we “fix.”

I think we’re moving toward something different:

Metabolism as something we support daily — through food, hydration, gut health, and the biological systems we nourish over time.

For the past year, I’ve been quietly studying this space and building around one core idea:

There may be a meaningful role for real functional food in the GLP-1 era — not as a replacement for medicine, but as nutritional support alongside metabolic health journeys.

Not a shortcut.

A system.

We’re still early in this conversation.

But if the last few years were about intervention…

the next few may be about recovery.

Curious what others in food, agriculture, metabolic health, and functional wellness are seeing emerge in this space.

— Bevin Brooks

References

Solverson, P., Teets, C., Rust, B., Johnson, S.A., et al. (2024). A One-Week Elderberry Juice Intervention Augments the Fecal Microbiota and Suggests Improvement in Glucose Tolerance and Fat Oxidation in a Randomized Controlled Trial. Nutrients, 16(20), 3555.

Wilding, J.P.H., Batterham, R.L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002.

Wilding, J.P.H., Jacobsen, L.V., le Roux, C.W., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564.

Lee, J., & Finn, C.E. (2007). Anthocyanins and Other Polyphenolics in American Elderberry (Sambucus canadensis) and European Elderberry (Sambucus nigra) Cultivars. Journal of the Science of Food and Agriculture, 87(14), 2665–2675.

Özgen, M., Scheerens, J.C., Reese, R.N., & Miller, R.A. (2010). Total Phenolic, Anthocyanin Contents and Antioxidant Capacity of Selected Elderberry Accessions. Pharmacognosy Magazine, 6(23), 198–203.

Sadilova, E., Stintzing, F.C., & Carle, R. (2006). Thermal degradation of acylated and nonacylated anthocyanins. Journal of Food Science, 71(8), C504–C512.

Fuleki, T., & Francis, F.J. (1968). Quantitative Methods for Anthocyanins: Stability of Elderberry Pigments. Journal of Food Science, 33(1), 72–79.

Chambers, E.S., Preston, T., Frost, G., & Morrison, D.J. (2018). Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health. Current Nutrition Reports, 7, 198–206.